Key Pharmacology Equations

Why This Matters

Pharmacology equations aren't just math problems—they're the tools that connect drug properties to clinical decisions. When you're tested on these concepts, you're really being asked to demonstrate understanding of pharmacokinetics (what the body does to the drug) and pharmacodynamics (what the drug does to the body). Every equation here answers a practical question: How much drug should I give? How often? How long until it works? Why does this patient need a different dose?

These equations reveal the underlying principles of drug absorption, distribution, metabolism, and elimination (ADME). You'll see connections between concepts like clearance and half-life, or between volume of distribution and loading dose. Don't just memorize formulas—know what each variable represents, when you'd use each equation clinically, and how changing one parameter affects the others.

---

Distribution and Dosing Fundamentals

These equations describe how drugs spread through the body and how we calculate initial doses. The key principle: a drug's distribution pattern determines how much you need to give to achieve target concentrations.

Volume of Distribution (Vd)

• $V_d = \frac{\text{Dose}}{C_0}$—where $C_0$ is initial plasma concentration; this is a theoretical volume, not an actual body compartment
• High Vd values (>40 L) indicate extensive tissue binding or lipophilic drugs that leave the plasma and accumulate in tissues
• Low Vd values (~3-5 L) suggest the drug stays primarily in plasma, often due to high protein binding or hydrophilicity

Loading Dose Equation

• $\text{Loading Dose} = V_d \times C_{target}$—used to rapidly achieve therapeutic concentrations without waiting for steady-state
• Essential for emergencies or drugs with long half-lives where waiting 4-5 half-lives isn't clinically acceptable
• Bypasses accumulation time by front-loading the amount needed to fill the entire volume of distribution at once

---

Elimination and Maintenance

These equations govern how drugs leave the body and how we maintain therapeutic levels. The core principle: clearance and half-life determine how often you dose and how much you give to keep levels steady.

Clearance Equation

• $CL = \frac{\text{Rate of Elimination}}{C_p}$ or $CL = k_e \times V_d$—represents the volume of plasma completely cleared of drug per unit time
• Organ-specific clearance includes renal clearance ($CL_R$) and hepatic clearance ($CL_H$); total clearance is their sum
• Clinical adjustment required when renal or hepatic function declines—reduced clearance means drug accumulation and potential toxicity

Drug Half-Life Equation

• $t_{1/2} = \frac{0.693 \times V_d}{CL}$—the 0.693 comes from $\ln(2)$, reflecting first-order elimination kinetics
• Determines dosing interval—most drugs are dosed every 1-2 half-lives to maintain therapeutic range
• Steady-state reached in 4-5 half-lives regardless of dose; this is when drug input equals drug output

Maintenance Dose Equation

• $\text{Maintenance Dose} = CL \times C_{ss} \times \tau$—where $C_{ss}$ is steady-state concentration and $\tau$ is the dosing interval
• Balances elimination—you're replacing exactly what the body clears between doses
• Directly proportional to clearance—patients with reduced kidney or liver function need lower maintenance doses

---

Absorption and Bioavailability

These equations address how much drug actually reaches systemic circulation. The principle: not all of an administered dose makes it to the bloodstream—these equations quantify what does.

Bioavailability Equation

• $F = \frac{AUC_{oral}}{AUC_{IV}} \times 100\%$—IV administration is the reference (F = 100%) since it bypasses absorption barriers
• First-pass metabolism is the primary reason oral bioavailability drops; drugs absorbed from the GI tract pass through the liver before reaching systemic circulation
• Formulation matters—extended-release, enteric-coated, and different salt forms can dramatically alter F for the same drug

Area Under the Curve (AUC)

• $AUC = \frac{F \times \text{Dose}}{CL}$—represents total drug exposure over time, measured in concentration × time units (e.g., mg·hr/L)
• Gold standard for bioequivalence—generic drugs must demonstrate AUC within 80-125% of brand-name to gain approval
• Integrates absorption and elimination—a larger AUC means either more drug absorbed, slower clearance, or both

---

Ionization and pH Effects

This equation explains how environmental pH affects drug behavior. The principle: most drugs are weak acids or bases, and their ionization state determines absorption, distribution, and excretion.

Henderson-Hasselbalch Equation

• For weak acids: $pH = pK_a + \log\frac{[A^-]}{[HA]}$—the ionized form ($A^-$) is water-soluble but cannot cross membranes
• For weak bases: $pH = pK_a + \log\frac{[B]}{[BH^+]}$—the un-ionized form (B) is lipid-soluble and crosses membranes readily
• Ion trapping principle—weak acids accumulate in basic environments (and vice versa); this explains why aspirin overdose is treated with urine alkalinization

---

Enzyme Kinetics and Drug Response

These equations describe how drugs interact with biological systems at the molecular level. The principle: drug effects depend on receptor binding and enzyme activity, which can be saturated at high concentrations.

Michaelis-Menten Equation

• $v = \frac{V_{max} \times [S]}{K_m + [S]}$—describes reaction velocity as a function of substrate concentration
• $K_m$ (Michaelis constant) equals the substrate concentration at half-maximal velocity; lower $K_m$ means higher enzyme affinity
• Saturation kinetics—at low [S], the reaction is first-order; at high [S], it becomes zero-order (rate independent of concentration)

Dose-Response Curve Equation

• $E = \frac{E_{max} \times [D]}{EC_{50} + [D]}$—mathematically identical to Michaelis-Menten but describes pharmacodynamic response
• $EC_{50}$ defines potency—the concentration producing 50% of maximal effect; lower $EC_{50}$ = more potent drug
• $E_{max}$ defines efficacy—the maximum possible response; a full agonist has higher $E_{max}$ than a partial agonist

---

Quick Reference Table

---

Self-Check Questions

1. A drug has a very high volume of distribution (500 L). What does this tell you about its tissue binding, and how would this affect your loading dose calculation compared to a drug with Vd of 5 L?

2. Which two equations both use clearance as a key variable, and what different clinical questions do they answer?

3. Compare $K_m$ in the Michaelis-Menten equation to $EC_{50}$ in the dose-response equation—what do both values represent, and what does a lower value indicate in each case?

4. A patient with severe renal impairment needs a drug primarily eliminated by the kidneys. Using your knowledge of the maintenance dose equation, explain why and how you would adjust their dosing regimen.

5. Using the Henderson-Hasselbalch equation, predict whether a weak acid drug (pKa = 4) would be more ionized in the stomach (pH 2) or the intestine (pH 7). Which location would show better absorption, and why?